CKD-501 0.5mg
19DM05L
Phase 3 small_molecule completed
Quick answer
CKD-501 0.5mg for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at Hong Kong Baptist University with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Hong Kong Baptist University
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed